Assembly Biosciences, Inc. revenue breakdown overview

Assembly Biosciences, Inc. revenue for the last year amounted to 27.55 M EUR, the most of which — 27.55 M EUR — came from its highest performing source at the moment, Innovative Therapeutics Targeting Serious Viral Diseases, the year earlier bringing 6.49 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Assembly Biosciences, Inc. 27.55 M EUR, and the year before that — 6.49 M EUR.